15 results on '"Bubnova, Natalia"'
Search Results
2. Russia’s Policy and International Cooperation: The Challenges and Opportunities of Soft Power
3. Anemia in patients with necrotizing soft tissue infections, pathogenetic and prognostic value
4. METHODS OF VISUALIZATION OF MAST CELLS (LITERATURE REVIEW)
5. THE ROLE OF MAST CELLS IN CARCINOGENESIS (LITERATURE REVIEW)
6. THE CORRELATION BETWEEN THE CONCEPTS OF LINGUISTIC EFFECT AND MANIPULATION OF CONSCIOUSNESS
7. PSYCHOLINGUISTIC ASPECTS OF STUDY OF LINGUISTIC EFFECT AND MANIPULATION OF CONSCIOUSNESS
8. Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
9. To Discover the Future: About the Book by Alexander Yanov (2020), “Where Is Russia’s Place in History? The Riddle of Donald Treadgold”. Moscow: New Chronograph, 336 p.
10. CHANGES IN THE INDICATORS OF THE GENERAL BLOOD TEST AND COAGULOGRAM IN A MILD COURSE OF CORONAVIRUS INFECTION
11. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
12. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial
13. About and Based on the Book by Mikhail Taratuta “Russians and Americans”. Book review: Taratuta M. America and Russia. We are so Different. Moscow: Alpina Publisher; 2019. 318 p
14. Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
15. Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.